Compare, Analyse STRIDES PHARMA SCIENCE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs MYLAN (US) - Comparison Results

STRIDES PHARMA SCIENCE     Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES PHARMA SCIENCE   MYLAN
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-18
MYLAN
Dec-18
STRIDES PHARMA SCIENCE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,1473,398-   
Low Rs6421,870-   
Sales per share (Unadj.) Rs317.21,563.6-  
Earnings per share (Unadj.) Rs7.842.5-  
Cash flow per share (Unadj.) Rs25.1335.2-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs274.31,691.6-  
Shares outstanding (eoy) m89.50514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.7 167.4%   
Avg P/E ratio x114.062.0 183.8%  
P/CF ratio (eoy) x35.77.9 454.3%  
Price / Book Value ratio x3.31.6 209.4%  
Dividend payout %25.50-   
Avg Mkt Cap Rs m80,0581,355,343 5.9%   
No. of employees `0002.535.0 7.2%   
Total wages/salary Rs m4,3410-   
Avg. sales/employee Rs Th11,325.822,985.5 49.3%   
Avg. wages/employee Rs Th1,731.40-   
Avg. net profit/employee Rs Th280.1624.2 44.9%   
INCOME DATA
Net Sales Rs m28,394804,494 3.5%  
Other income Rs m9410-   
Total revenues Rs m29,334804,494 3.6%   
Gross profit Rs m3,965208,173 1.9%  
Depreciation Rs m1,540150,633 1.0%   
Interest Rs m1,96238,693 5.1%   
Profit before tax Rs m1,40318,847 7.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-1680-   
Extraordinary Inc (Exp) Rs m-4360-   
Tax Rs m97-2,998 -3.2%   
Profit after tax Rs m70221,845 3.2%  
Gross profit margin %14.025.9 54.0%  
Effective tax rate %6.9-15.9 -43.6%   
Net profit margin %2.52.7 91.1%  
BALANCE SHEET DATA
Current assets Rs m24,836449,229 5.5%   
Current liabilities Rs m18,993327,537 5.8%   
Net working cap to sales %20.615.1 136.0%  
Current ratio x1.31.4 95.3%  
Inventory Days Days7184 84.9%  
Debtors Days Days11393 121.5%  
Net fixed assets Rs m34,289156,059 22.0%   
Share capital Rs m895428 208.9%   
"Free" reserves Rs m23,6510-   
Net worth Rs m24,546870,315 2.8%   
Long term debt Rs m15,513939,350 1.7%   
Total assets Rs m65,4372,334,524 2.8%  
Interest coverage x1.71.5 115.3%   
Debt to equity ratio x0.61.1 58.6%  
Sales to assets ratio x0.40.3 125.9%   
Return on assets %4.12.6 157.0%  
Return on equity %2.92.5 114.0%  
Return on capital %6.93.2 216.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m14,9620-   
CASH FLOW
From Operations Rs m1,871167,174 1.1%  
From Investments Rs m5,826-86,410 -6.7%  
From Financial Activity Rs m-10,157-77,879 13.0%  
Net Cashflow Rs m-2,6151,385 -188.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare STRIDES PHARMA SCIENCE With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STRIDES PHARMA SCIENCE With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC LTD  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

Sensex Opens Flat; Telecom and Automobiles Stocks Lose(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.1% while the Hang Seng is down 0.1%.

Related Views On News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Oct 18, 2019 09:43 AM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS